Table 4.

WASP hotspot mutations and clinical phenotype


Mutation

Affected families (no. patients)

% of total families

Score 1-2.5*, no. patients

Score 3-5, no. patients
168C > T (T45M)   7 (8)   (3.1)   7   0  
290C > N/291G > N (R86S/G/C/H/L)   17 (19)   (7.5)   19   0  
IVS6 + 5g > a fs stop aa 190/normal   6 (10)   (2.6)   9   1  
665C > T (R211X)   10 (11)   (4.4)   1   10  
IVS8 + 1g > a/c/t, fs stop aa246   10 (13)   (4.4)   5   6  
Totals
 
50 (61)
 
(22)
 
41
 
17
 

Mutation

Affected families (no. patients)

% of total families

Score 1-2.5*, no. patients

Score 3-5, no. patients
168C > T (T45M)   7 (8)   (3.1)   7   0  
290C > N/291G > N (R86S/G/C/H/L)   17 (19)   (7.5)   19   0  
IVS6 + 5g > a fs stop aa 190/normal   6 (10)   (2.6)   9   1  
665C > T (R211X)   10 (11)   (4.4)   1   10  
IVS8 + 1g > a/c/t, fs stop aa246   10 (13)   (4.4)   5   6  
Totals
 
50 (61)
 
(22)
 
41
 
17
 

Three of the hotspot mutations (T45M, R86N, IVS6 + 5g > a) are associated with low scores, and 2 hotspot mutations (R211X, IVS8 + 1g > a) are associated with high scores (ϰ2 = 36.11, 4 df, P < .001). Fisher exact test for r × c tables, P < .001.

*

A score of 2 to 3 is listed as a score of 2.5; scores 1 to 2.5 are considered XLT; scores of 3 to 5 represent the WAS phenotype.

One patient with the 168C > T missense mutation and 2 patients with the IVS8 + 1g > a spalice site mutation could not be scored because of insufficient clinical data.

or Create an Account

Close Modal
Close Modal